From major journals, first or last author from the Institute for Cancer Research
The innate power of natural killer cells in cancer therapy
Nat Med (in press)
DOI 10.1038/s41591-025-03712-9, PubMed 40355615
SNX10 at the crossroad of endocytosis and piecemeal mitophagy
Autophagy, 1-3 (in press)
DOI 10.1080/15548627.2025.2499641, PubMed 40327657
Real-world comparison of pembrolizumab alone and combined with chemotherapy in metastatic lung adenocarcinoma patients with PD-L1 expression ≥50
ESMO Open, 10 (5), 105073 (in press)
DOI 10.1016/j.esmoop.2025.105073, PubMed 40305908